DrugPatentWatch Database Preview

Details for Patent: 7,967,011

« Back to Dashboard

Which drugs does patent 7,967,011 protect, and when does it expire?

Patent 7,967,011 protects SYMBICORT and is included in one NDA.

Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-one patent family members in twenty-four countries.

Summary for Patent: 7,967,011

Title:	Inhalation device
Abstract:	Actuator for an inhaler for delivering medicament by inhalation, having a mouthpiece for guiding medicament to the mouth of a user; and a removable protection cap for the mouthpiece. The cap is secured to the mouthpiece by a cap retaining member that engages a mating recess in the mouthpiece outer periphery. The cap includes at least one release button arranged to provide an elastic deformation of the cap inner periphery that disengages the cap retaining member from the recess.
Inventor(s):	Hodson; Darren (Shropshire, GB), Rasmussen; Jorgen (Struer, DK)
Assignee:	AstraZeneca AB (Sodertalje, SE)
Application Number:	11/346,558
Patent Claim Types: see list of patent claims	Delivery;

Drugs Protected by US Patent 7,967,011

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Astrazeneca	SYMBICORT	budesonide; formoterol fumarate dihydrate	AEROSOL, METERED;INHALATION	021929-001	Jul 21, 2006		RX	Yes	Yes					Y
Astrazeneca	SYMBICORT	budesonide; formoterol fumarate dihydrate	AEROSOL, METERED;INHALATION	021929-002	Jul 21, 2006		RX	Yes	Yes					Y

Foreign Priority and PCT Information for Patent: 7,967,011

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	9704185	Nov 14, 1997

Non-Orange Book US Patents Family Members for Patent 7,967,011

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,584,668	Inhalation device
6,805,116	Inhalation device
7,743,765	Inhalation device
7,367,333	Inhalation device

International Family Members for US Patent 7,967,011

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	1183699
Australia	1266799
Australia	728125
Australia	750351